As shown in Figure 4A, breast cancer, head and neck cancer, cholangiocarcinoma, endometrial cancer, esophagogastric cancer, and ovarian and bladder cancer exhibited the highest alteration frequency, with amplification of RPS6KB2 being the most common copy number alteration. This evidence concerns the gene RPS6KB2 and urinary bladder cancer.